各基因型 H 型高血压病患者血清鸢尾素水平分析
摘要
关键词
全文:
PDF参考
[1]Hou N, Han F, Sun X. The relationship between circulating irisin levels and endothelial function in lean and obese subjects. Clin Endocrinol (Oxf) 2015; 83(3): 339-343.[2] Sena CM,Pereira AM,Seica R. Endothelial dysfunction-a major mediator of diabetic vascular disease[J]. Biochim Biophys Acta, 2013,1832( 12) : 2216 - 2231.[3] Paneni F,Beckman JA,Creager MA,et al. Diabetes and vascular disease: pathophysiology,clinical consequences,and medical therapy: part I[J].Eur Heart J,2013,34( 31) : 2436 - 2443.[4]Lu JY (卢俊颜),Xiang GD,Mei W, Liu M,Xiang L,Dong J.Irisin improving atherosclerosis condition in apoE-/- diabetesmellitus mice. Chin Circ J (中国循环杂志) 2015;30(5): 492–497 (in Chinese with English abstract).[5]Tofler GH,Dagostino RB,Jacques PF,et al. Association between increased homocysteine levels and impaired fibrinolytic potential: mechanism for cardiovascular risk[J].Thromb Haemost,2002,88(5):799-804.[6]赵宝华,张硕锐,李长明,等.叶酸辅助治疗对 H 型高血压患者同型半胱氨酸水平及脑卒中发病率的影响[J].中国药业,2018,27 (5) :39 - 41.[7]陈磊.青海地区汉族H型高血压人群与 MTHFRC677T 基因多态性的相关性研究[D].青海:宁夏医科大学,2016.[8]张岩,霍 勇.伴同型半胱氨酸升高的高血压—“H 型”高血压[J].心血管病学进展,2011,32(1):3-6.[9]Hou N, Han F, Sun X. The relationship between circulatingirisin levels and endothelial function in lean and obese subjects. Clin Endocrinol (Oxf) 2015; 83(3): 339-343.[10]张云飞,徐炳欣,赵艳,吴帆,杨琼琼.MTHFR C677T 基因多态性对 H 型高血压患者叶酸降低同型半胱氨酸治疗的影响[J].河南医学研究,2020,29 (12):2135-2138.
DOI: http://dx.doi.org/10.12361/2661-3603-05-01-113841
Refbacks
- 当前没有refback。